ArticleBlood advances2025

Outcomes of bispecific antibody therapy after CAR T-cell failure in relapsed/refractory large B-cell lymphoma.

Evgenii Shumilov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.